Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Baumgart

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Deutsches Arzteblatt International|February 12, 2025
The Administrative Prevalence and Pharmacotherapy of Chronic Inflammatory Bowel Diseases, 2012–2020Karsten H Weylandt, Astrid Wiese, Adelheid Jung, et al.
Therapeutic Advances in Gastroenterology|March 1, 2024
Stricture dilation <i>via</i> balloon-assisted endoscopy in Crohn's disease: approach and intraprocedural outcomes with the single-balloon and double-balloon systemsBrendan P Halloran, Matthew Reeson, Christopher Teshima, et al.
Infection and Immunity|February 26, 2005
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signalingAndreas Sturm, Klaus Rilling, Daniel C Baumgart, et al.
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical ProgrammeKevin L Winthrop, Edward V Loftus, Daniel C Baumgart, et al.
Scandinavian Journal of Gastroenterology|April 4, 2014
MRI-guided percutaneous transhepatic cholangiodrainage: feasibility study in a porcine modelIoannis S Papanikolaou, Ivo R van der Voort, Sascha S Chopra, et al.
Radiology|May 16, 2018
US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver DiseaseChristian A Hudert, Heiko Tzschätzsch, Jing Guo, et al.
Digestion|January 5, 2008
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel diseaseDaniel C Baumgart, Carsten Buning, Lars Geerdts, et al.
Zeitschrift Fur Gastroenterologie|July 20, 2021
[Position paper on endoscopic reporting in IBD]Carsten Schmidt, Oliver Bachmann, Daniel C Baumgart, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Deutsches Arzteblatt International|February 12, 2025
The Administrative Prevalence and Pharmacotherapy of Chronic Inflammatory Bowel Diseases, 2012–2020Karsten H Weylandt, Astrid Wiese, Adelheid Jung, et al.
Therapeutic Advances in Gastroenterology|March 1, 2024
Stricture dilation <i>via</i> balloon-assisted endoscopy in Crohn's disease: approach and intraprocedural outcomes with the single-balloon and double-balloon systemsBrendan P Halloran, Matthew Reeson, Christopher Teshima, et al.
Infection and Immunity|February 26, 2005
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signalingAndreas Sturm, Klaus Rilling, Daniel C Baumgart, et al.
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical ProgrammeKevin L Winthrop, Edward V Loftus, Daniel C Baumgart, et al.
Scandinavian Journal of Gastroenterology|April 4, 2014
MRI-guided percutaneous transhepatic cholangiodrainage: feasibility study in a porcine modelIoannis S Papanikolaou, Ivo R van der Voort, Sascha S Chopra, et al.
Radiology|May 16, 2018
US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver DiseaseChristian A Hudert, Heiko Tzschätzsch, Jing Guo, et al.
Digestion|January 5, 2008
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel diseaseDaniel C Baumgart, Carsten Buning, Lars Geerdts, et al.
Zeitschrift Fur Gastroenterologie|July 20, 2021
[Position paper on endoscopic reporting in IBD]Carsten Schmidt, Oliver Bachmann, Daniel C Baumgart, et al.
Pageof 13